Evaluating Modeling and Validation Strategies for Tooth Loss.


Journal

Journal of dental research
ISSN: 1544-0591
Titre abrégé: J Dent Res
Pays: United States
ID NLM: 0354343

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 31 7 2019
medline: 18 7 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Prediction models learn patterns from available data (training) and are then validated on new data (testing). Prediction modeling is increasingly common in dental research. We aimed to evaluate how different model development and validation steps affect the predictive performance of tooth loss prediction models of patients with periodontitis. Two independent cohorts (627 patients, 11,651 teeth) were followed over a mean ± SD 18.2 ± 5.6 y (Kiel cohort) and 6.6 ± 2.9 y (Greifswald cohort). Tooth loss and 10 patient- and tooth-level predictors were recorded. The impact of different model development and validation steps was evaluated: 1) model complexity (logistic regression, recursive partitioning, random forest, extreme gradient boosting), 2) sample size (full data set or 10%, 25%, or 75% of cases dropped at random), 3) prediction periods (maximum 10, 15, or 20 y or uncensored), and 4) validation schemes (internal or external by centers/time). Tooth loss was generally a rare event (880 teeth were lost). All models showed limited sensitivity but high specificity. Patients' age and tooth loss at baseline as well as probing pocket depths showed high variable importance. More complex models (random forest, extreme gradient boosting) had no consistent advantages over simpler ones (logistic regression, recursive partitioning). Internal validation (in sample) overestimated the predictive power (area under the curve up to 0.90), while external validation (out of sample) found lower areas under the curve (range 0.62 to 0.82). Reducing the sample size decreased the predictive power, particularly for more complex models. Censoring the prediction period had only limited impact. When the model was trained in one period and tested in another, model outcomes were similar to the base case, indicating temporal validation as a valid option. No model showed higher accuracy than the no-information rate. In conclusion, none of the developed models would be useful in a clinical setting, despite high accuracy. During modeling, rigorous development and external validation should be applied and reported accordingly.

Identifiants

pubmed: 31361174
doi: 10.1177/0022034519864889
pmc: PMC6710618
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1088-1095

Références

J Clin Periodontol. 1975 Aug;2(3):126-35
pubmed: 1058213
Oral Health Prev Dent. 2003;1(1):7-16
pubmed: 15643744
J Clin Periodontol. 2007 Mar;34(3):226-31
pubmed: 17257157
J Periodontol. 2009 Mar;80(3):476-91
pubmed: 19254132
J Clin Periodontol. 2011 Aug;38(8):707-14
pubmed: 21627675
J Clin Periodontol. 2013 Mar;40(3):203-11
pubmed: 23379538
Acta Odontol Scand. 2014 Feb;72(2):81-91
pubmed: 23998481
J Clin Periodontol. 2014 Mar;41(3):224-31
pubmed: 24313816
Biomark Res. 2015 Jan 24;3(1):2
pubmed: 25642328
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
J Dent Res. 2015 Jun;94(6):777-86
pubmed: 25818586
J Clin Periodontol. 2015 Jun;42(6):513-9
pubmed: 25970318
J Clin Epidemiol. 2016 Jan;69:245-7
pubmed: 25981519
Adv Anat Pathol. 2015 Sep;22(5):303-5
pubmed: 26262512
J Clin Periodontol. 2015 Dec;42(12):1115-25
pubmed: 26498672
BMC Med Res Methodol. 2017 Apr 19;17(1):63
pubmed: 28420342
J Clin Periodontol. 2017 Nov;44(11):1145-1152
pubmed: 28800151
J Clin Periodontol. 2018 Jan;45(1):46-55
pubmed: 28871596
J Clin Epidemiol. 2018 Jun;98:133-143
pubmed: 29174118
J Clin Periodontol. 2018 Jun;45(6):701-710
pubmed: 29611218
J Dent. 2019 Jan;80:49-54
pubmed: 30389428
J Clin Periodontol. 2018 Dec;45(12):1408-1420
pubmed: 30394558
Oral Sci Rev. 1977;10:11-43
pubmed: 335305
J Periodontol. 1996 Jul;67(7):666-74
pubmed: 8832477

Auteurs

J Krois (J)

1 Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin Berlin, Berlin, Germany.

C Graetz (C)

2 Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

B Holtfreter (B)

3 Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Greifswald, Germany.

P Brinkmann (P)

2 Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

T Kocher (T)

3 Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Greifswald, Germany.

F Schwendicke (F)

1 Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH